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Background: Accurate quantification of mitral valve (MV) morphology and dynamic behavior over 
the cardiac cycle is crucial to understand the mechanisms of degenerative MV dysfunction and to guide 
the surgical intervention. Cardiac magnetic resonance (CMR) imaging has progressively been adopted 
to evaluate MV pathophysiology, although a dedicated framework is required to perform a quantitative 
assessment of the functional MV anatomy.
Methods: We investigated MV dynamic behavior in subjects with normal MV anatomy (n=10) and patients 
referred to surgery due to degenerative MV prolapse, classified as fibro-elastic deficiency (FED, n=9) and 
Barlow’s disease (BD, n=10). A CMR-dedicated framework was adopted to evaluate prolapse height and 
volume and quantitatively assess valvular morphology and papillary muscles (PAPs) function over the cardiac 
cycle. Multiple comparison was used to investigate the hallmarks associated to MV degenerative prolapse and 
evaluate the feasibility of anatomical and functional distinction between FED and BD phenotypes. 
Results: On average, annular dimensions were significantly (P<0.05) larger in BD than in FED and 
normal subjects while no significant differences were noticed between FED and normal. MV eccentricity 
progressively decreased passing from normal to FED and BD, with the latter exhibiting a rounder annulus 
shape. Over the cardiac cycle, we noticed significant differences for BD during systole with an abnormal 
annular enlargement between mid and late systole (LS) (P<0.001 vs. normal); the PAPs dynamics remained 
comparable in the three groups. Prolapse height and volume highlighted significant differences among 
normal, FED and BD valves.
Conclusions: Our CMR-dedicated framework allows for the quantitative and dynamic evaluation of 
MV apparatus, with quantifiable annular alterations representing the primary hallmark of severe MV 
degeneration. This may aid surgeons in the evaluation of the severity of MV dysfunction and the selection of 
the appropriate MV treatment.
Keywords: Degenerative mitral valve (MV) disease; MV prolapse; cardiac magnetic resonance (CMR); fibro-
elastic deficiency (FED); Barlow’s disease (BD)
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Introduction
Degenerative mitral valve (MV) disease is a frequent 
disorder affecting around 2% of the population (1) and MV 
leaflet prolapse represents its most common finding, usually 
due to rupture of chordae tendineae and resulting in MV 
regurgitation (2). In particular, a progressive spectrum of 
degenerative MV disease is evident in the clinical practice, 
ranging from fibro-elastic deficiency (FED) to Barlow’s 
disease (BD) (3). The former generally involves prolapse 
of an isolated segment due to single chordal rupture in a 
normally shaped valve; the latter is associated with multi-
segment prolapse due to multiple chordal rupture or 
elongation, significant excess of leaflet tissue and large 
annular size. According to the Carpentier’s functional 
classification (4), a precise localization of the pathology 
and the identification of concomitant MV lesions and 
abnormalities are crucial to elucidate the mechanism of MV 
dysfunction and manage the reconstructive surgical repair.
At this  a im,  three-dimensional  (3D) real-t ime 
transesophageal echocardiography (RT-TEE) represents the 
gold standard to accurately characterize MV prolapse (5-8) 
and it is highly recommended for intraoperative guidance 
during surgical MV repair (9,10). In addition, cardiac 
magnetic resonance (CMR) imaging has progressively 
emerged as a valid noninvasively modality to evaluate 
the functional MV anatomy in normal and prolapsed 
scenarios (11-14). However, no specific recommendations 
or quantitative in vivo imaging predictors are currently 
available to objectively characterize the MV dysfunction and 
to systematically differentiate MV degenerative phenotypes, 
e.g., FED from BD (15).
For this purpose, in order to gain objective insight into 
MV degenerative alterations, we exploited a CMR-dedicated 
framework able to combine a standard radiological 
approach with a quantitative in vivo assessment of MV 
anatomy and function. The former consists of a rotational 
CMR sequence of acquisition, available on common 
CMR machines, to acquire the entire MV apparatus 
throughout the cardiac cycle; the latter, taking advantage 
of bioengineering methods, automatically computes the 
dynamic time course of several MV characteristics in order 
to investigate CMR-derived hallmarks associated to MV 
disease and identify phenotypic differences. Accordingly, 
the analysis was accomplished in patients referred to surgery 
for degenerative MV prolapse repair due to FED and BD, 
using a cohort of normal volunteers as a physiological term 
of comparison.
Methods
 
CMR imaging
At a single university hospital, CMR acquisitions were 
performed on 10 BD and 9 FED selected patients, 
undergoing repair for degenerative MV prolapse, and 10 
control subjects who did not have any discernible MV 
pathology. Participants referred to surgery for MV prolapse 
repair but reporting contraindications to CMR imaging 
were excluded from the study. At the time of surgery, the 
surgical diagnosis of MV degenerative phenotype was 
classified as either BD or FED, according to standard 
clinical criteria (7,8,16). The Div. Cardiac Surgery 
Institutional Review Board approved the study and all the 
participants gave informed consent (MU 301390710 Rev. 
02-03.07.14).
Each CMR acquisition was accomplished adopting 
a customized technique (17,18) carried out on a 3.0T 
TX Achieva (Philips Medical System, Irvine, California) 
machine: cine images were obtained through 18 long-axis 
planes, evenly rotated along the LV axis every 10 degrees 
with the LV axis of rotation defined as the segment 
connecting LV apex and MV centroid (Figure 1A). An 
isotropic pixel spacing of 1.25 mm and a slice thickness of 
8 mm were adopted. Enabling the breath-holding modality, 
30 cardiac phases were recorded on each plane, with 
different temporal resolution according to the characteristic 
R-R interval of each patient. For each acquisition, a set 
of 540 DICOM images were obtained, requiring a total 
acquisition time of about 10 minutes.
CMR images processing
Offline processing of CMR images was completely 
performed on a dedicated platform we developed 
in MATLAB (The MathWorks Inc. ,  Natick,  MA, 
United States) (17), including the segmentation of 
MV substructures on CMR images, the automatic 3D 
reconstruction of MV geometry and the quantitative 
analysis of the anatomical and functional key-aspects related 
to MV prolapse.
The procedure of CMR segmentation has already been 
exploited in previous works of the group for the numerical 
modeling of the MV patient-specific anatomy in order 
to deepen the mechanisms underlying MV prolapse and 
investigate the effects of different MV surgical repair 
techniques (18-20) or percutaneous approaches (21,22). 
Briefly, as reported in Figure 1B for a single frame of the 
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R-R interval, two points (in red color) were manually 
selected on MV annulus in each of the acquired plane; the 
papillary muscles (PAPs), where visible, were added through 
a variable number of points (green points), selecting single 
points or defining a region of interest (ROI), i.e., selecting 
all the pixels inside it. In particular, MV segmentation was 
performed at six characteristic phases during the cardiac 
cycle: in early, mid, and late diastole (LD) and early, mid 
and late systole (LS). Specifically, early diastole (ED) was 
identified just after MV opening, LD as preceding MV 
closure, and mid diastole (MD) as midway between ED 
and LD. Early systole (ES) was identified as immediately 
after onset of MV closure, LS at or immediately before AV 
closure, and mid systole (MS) as midway between ES and 
LS (6,7). In addition, at MS, multiple points were selected 
on the MV leaflets profile on each tomographic CMR 
plane; for each leaflet, traced points were sampled in 32 
points equally redistributed between the annulus and the 
free margin (Figure 1B).
The 3D coordinates of the points selected on each CMR 
cut-plane were reconstructed from the position of the latter 
with respect to the CMR rotation axis. At this purpose, 
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Figure 1 Procedure of CMR-dedicated reconstruction of the MV dynamics over the cardiac cycle. (A) CMR rotational sequence of 
acquisition; (B) segmentation of MV sub-structures; (C) automatic 3D reconstruction of the MV annulus and of the PAPs tips; (D) automatic 
reconstruction, at MS, of the MV leaflets surface. MV, mitral valve; LV, left atrium; CMR, cardiac magnetic resonance; PAP, papillary muscle.
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further technical details can be found in the supplementary 
Appendix I available online.
Subsequently, the geometry of MV annulus was 
automatically reconstructed (Figure 1C) through a two-step 
validated procedure (22). First, a cylindrical reference frame 
was set with the origin in the centroid (O) of the extracted 
cloud of annular points, and the z-axis normal to the least-
square plane of the annular points defined. Second, in this 
local reference frame (Figure 1C), the radial (ρ) and axial 
(z) positions of the points belonging to the annular profile 
were approximated through a 4th order Fourier function of 
the angular position (ϑ). Finally, we identified four annular 
reference points (13): the saddle horn (SH), the midpoint 
of the posterior annulus (P2), the anterolateral (CAL) and 
the posteromedial (CPM) commissures. The 3D coordinates 
of both anterolateral (PAPAL) and posteromedial (PAPPM) 
PAPs tips were identified applying a K-means partitioning 
algorithm to separate the cloud of selected papillary points 
during segmentation in two mutually exclusive clusters, thus 
identifying the centroid of each PAP tip.
At MS, the surface of MV leaflets was automatically 
reconstructed through triangulation, i.e., Delaunay 
tessellation of leaflet profile points and displayed as a color-
coded 3D-rendered surface to highlight the entity of MV 
bulging into the LA (Figure 1D)
Quantitative MV analysis 
At the defined six cardiac phases, our platform automatically 
computed MV dimensions and relationships between 
MV sub-structures (Figure 2). Specifically, the following 
measurements were computed on each dataset: 
(I) 2D annular area (A2D), i.e., the projection of the 
area included in MV annulus on the annular plane 
(Figure 2A);
(II) 3D annular area (A3D), as the area of 3D minimal 
surface analytically defined fit to the nonplanar 
annulus (Figure 2B);
(III) 3D annular perimeter (Pe, Figure 2C);
(IV) maximum annular height (HMAX) defined as the 
maximal vertical (i.e., perpendicular to the annular 
fitting plane) distance between the highest and 
lowest annular points (Figure 2B);
(V) intercommissural (DCC) and anteroposterior (DAP) 
diameters (Figure 2C,D). The former was defined as 
the distance between the posteromedial (PM) and 
anterolateral (AL) horns of the annulus; the latter 
was computed as the length of segment connecting 
the SH with the middle posterior scallop (P2), 
passing through the annular centroid (O);
(VI) eccentricity (e), defined as the intercommissural to 
anteroposterior diameter ratio (DCC/DAP);
(VII) longitudinal displacement of the annular centroid 
(∆LO), with respect to its initial position at late 
diastole, along the axis perpendicular to the 
annular plane (Figure 2B);
(VIII) distance of the MV centroid O from the AL (DAL,O) 
and PM (DPM,O) PAPs tips, respectively (Figure 2E);
(IX) distance between AL and PM PAPs tips (DPAPs) 
(Figure 2E);
(X) angle between PAPs (αPAPs) using the annular 
centroid O as the vertex of the angle (Figure 2F).
At MS, billowing volume (Vbillowing) and billowing height 
(Hbillowing) were added to the list of computed variables. We 
defined billowing of the leaflet (Figure 2G) as abnormal 
bowing of the leaflet toward the left atrium without involving 
the leaflet edge (23). With respect to the 3D nonplanar 
surface of the annulus (A3D), billowing volume was the 
volume included between the 3D nonplanar annular surface 
and the leaflets surface while billowing height represented 
the maximum height above this minimal surface (7).
Statistical analysis
All the statistical computations were performed in 
GraphPad Prism 7 (GraphPad Software Inc., La Jolla, 
CA, USA). Continuous variables were expressed as mean ± 
standard deviation (SD) and the normality of data 
distributions assessed through the Kolmogorov-Smirnov 
test. The comparison between group characteristics and 
overall static measurements, i.e., obtained by averages 
over the entire cardiac cycle, was accomplished through 
1-way ANOVA and Post hoc analysis done by applying 
the Bonferroni test. The Chi-square test was adopted to 
compare categorical variables. Changes in dynamic CMR-
derived variables were assessed using 2-way ANOVA for 
repeated measures with one factor analyzed as a repeated-
measure factor. Statistical significance was indicated by a 
probability value of P<0.05.
Results
The characteristics of enrolled participants are summarized 
in Table 1: participants were predominantly men and FED 
subjects were generally older than BD subjects (P<0.05). 
From groups comparison, no significant differences were 
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Figure 2 Definition of the computed CMR-derived measurements. (A) 2D annular area (A2D); (B) 3D annular area (A3D), maximum 
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noticed in terms of body surface area (BSA, P=0.33), body 
mass index (BMI, P=0.795) and heart rate (P=0.106), as 
measured before CMR acquisition.
Overall MV characteristics
The overall MV characteristics, computed by averages 
over the six cardiac phases, are reported in Table 2 for 
both mitral annulus and PAPs, including the billowing 
height and billowing volume computed at MS. Multiple 
significant morphological differences were reported for 
annular dimensions, in particular between BD and Normal 
and between FED and BD, respectively. Annular areas 
(A2D and A3D) and perimeter (Pe) were significantly larger 
in BD than in FED (P<0.03) and Normal (P<0.001), while 
no significant differences were noticed between FED and 
Normal (P=0.24). If compared to Normal, BD phenotype 
reported the largest intercommissural (DCC, P<0.001) and 
anteroposterior (DAP, P<0.001) diameters with an average 
increase equal to +21.4% and +34.1%, respectively. In FED 
cohort, DCC and DAP dimensions were higher than in the 
Normal, although reporting a limited increase of +6.5% 
in DCC (P=0.55) and +14.5% in DAP (P=0.07). Accordingly, 
the MV eccentricity progressively decreased passing from 
Normal to FED (P=0.006 with respect to Normal) and BD 
(P=0.009 with respect to Normal), with the latter showing 
a rounder annulus shape than in both Normal and FED 
phenotypes. 
Despite the computed morphological differences, 
both the FED and BD phenotypes reported an apically-
oriented displacement of the annulus (∆LO) comparable to 
Normal (P=0.21): the average ∆LO, reported as negative since 
computed below the annular plane, was equal to −5.0±1.1 mm 
in Normal, −4.2±0.9 mm in FED (P=0.68 vs. Normal) and 
−5.4±1.0 mm in BD (P=0.91 vs. Normal), respectively. 
When considering the subvalvular apparatus, all the groups 
exhibited comparable DAL, O (P=0.64) and DPM, O (P=0.43) 
distances of the two PAPs tips from the annular centroid O 
as well as not significantly differences in the interpapillary 
distance (DPAPs, P=0.06) and angle (αPAPs, P=0.48).
Dynamic MV changes over the cardiac cycle
Dynamic changes in both MV annulus dimensions and 
PAPs positon over the cardiac cycle are reported in Figure 3 
and Figure 4, respectively. For each computed variable, as 
detailed in Table 3 and Table 4, differences between groups 
as well as phasic changes within the same group were 
quantified.
As in Normal subjects, both phenotypes of MV prolapsed 
reported significant dynamic changes over the cardiac 
cycle (P Phase <0.001). Comparing the groups, significant 
differences were noticed in terms of annular dimensions 
(A2D, A3D, Pe, DCC and DAP, P Group ≤0.001), eccentricity 
(e, P<0.01) and height (HMax, P<0.03). In particular, during 
systole, Normal and FED reported a comparable transient 
early systolic contraction (Figure 3A-C) while in BD 
phenotype the contraction was followed by a higher degree 
of annular enlargement during mid and LS (P<0.001 vs. 
Normal), as clearly visible for A2D (Figure 3A, P Group × 
Phase <0.002), A3D (Figure 3B, P Group × Phase <0.004) and 
annular perimeter (Figure 3C, P Group × Phase <0.002). 
Differences in dynamic changes among the three groups 
were noticed also for DCC (Figure 3E, P Group × Phase 
=0.024) and DAP (Figure 3F, P Group × Phase =0.040) 
with the intercommissural diameter (Figure 3E) reporting 
Table 1 Characteristics of the participants collected before CMR acquisitions
Participants characteristics Normal (n=10) FED (n=9) BD (n=10) P-value
Age (y) 35±7 75±6*,# 58±8* <0.0001
Female sex [n (%)] 3 [30] 4 [44] 2 [20] 0.5143
Height (cm) 177±6 167±9 172±9 0.0617
Weight (kg) 78±13 76±16 80±9 0.7213
BSA (m2) 1.98±0.1 1.85±0.2 1.91±0.2 0.3342
BMI (kg/m2) 25.9±3.6 26.9±3.9 26.7±2.3 0.7945
Heart rate (bpm) 66±8 67±10 74±9 0.1060
Data expressed as mean ± SD. One-way ANOVA (Bonferroni post hoc): *, P<0.05 versus normal subjects; #, P<0.05 versus BD. FED, 
fibroelastic deficiency; BD, Barlow disease; BSA, body surface area.
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in the BD phenotype a significant enlargement at MS 
and LS with respect to both FED (P<0.015) and Normal 
(P<0.001) subjects, exhibiting a comparable behaviour 
(P>0.05) in terms of DCC and DAP during systole. The 
annular eccentricity (Figure 3G) remained permanently 
higher in Normal compared to FED and BD phenotypes (P 
Group =0.008). In all the three groups, annular eccentricity 
progressively improved during diastole and reached the 
maximum value at ES, which was equal to 1.34±0.09 mm 
in Normal, 1.26±0.11 mm in FED (P>0.05 vs. Normal) and 
1.21±0.11 mm in BD (P=0.03 vs. Normal), respectively. 
Within each group, HMax reported dynamic changes 
throughout the cardiac cycle (Figure 3D, P Phase <0.001).
The time course of the apically-oriented annular 
displacement (∆LO, Figure 3H) was superimposable for 
all the groups (P Group =0.231): taking LD as temporal 
reference for ∆LO computation, a dynamic pattern (P 
Phase <0.001) was visible over the cardiac cycle, reaching 
the highest excursion below the MV plane at LS: −10.6± 
2.1 mm, −9.5±2.2 mm and −10.8±3.4 mm in Normal, FED 
and BD, respectively.
The dynamic PAPs behavior (Table 4, Figure 4) was 
comparable in the three groups during both diastole and 
systole, with all the four variables reporting P Group >0.05 
and P Phase <0.001. Indeed, the PAPs tips moved away from 
the MV centroid during diastolic LV filling while closing 
the gap on it during systole, with a comparable pattern 
of dynamic changes between the AL (Figure 4A) and the 
PM (Figure 4B) PAP. In the same way, both interpapillary 
distance (DPAPs, Figure 4C) and angle (αPAPs, Figure 4D) 
increased during diastole and decreased during systolic LV 
shrinking.
MV billowing
At MS, significant differences were found comparing the 
groups in terms of billowing height (P<0.001) and billowing 
volume (P<0.001) as reported in Table 2. Billowing height 
(Figure 5A) was almost negligible in Normal subjects while 
it ranged between 5.39±2.49 mm in FED (P<0.001 vs. 
Normal) and 7.76±2.41 mm in BD (P<0.001 vs. Normal). 
Billowing volume (Figure 5B) was an order of magnitude 
higher in BD than in FED (P=0.005) due to the larger 
extension of MV prolapsing surface, while a smaller though 
significant difference was noticed between FED and 
Normal (P<0.03). It is worth noting that the scatter plot 
(Figure 5C) created using the two variables as the horizontal 
(HBillowing) and the vertical (VBillowing) axis (8) facilitate 
Table 2 CMR-derived MV overall characteristics
Variables Normal FED BD P-value
A2D (cm
2) 11.6±1.7 14.2±2.3§ 18.5±4.6* 0.0002
A3D (cm
2) 12.4±1.8 15.4±2.4§ 19.7±5.0* 0.0003
Pe (cm) 12.7±0.9 14.1±1.1§ 15.8±1.9* 0.0002
DCC (mm) 41.9±3.8 44.6±3.5
§ 50.9±5.4* 0.0003
DAP (mm) 33.1±2.5 37.9±3.2
§ 44.4±6.2* <0.0001
e (−) 1.27±0.09 1.18±0.06 1.16±0.08* 0.0081
HMAX (mm) 8.0±1.7 10.2±2.6 10.6±1.9
* 0.0292
∆L (mm) −4.2±0.9 −5.3±1.8 −5.0±1.1 0.2105
DAL,O (mm) 35.6±3.2 37.2±6.7 37.8±5.8 0.6377
DPM,O (mm) 37.9±4.6 37.1±5.8 40.1±5.1 0.4248
DPAPs (mm) 28.6±2.2 27.9±2.4 31.8±5.2 0.0567
αPAPs (°) 45.6±4.4 44.3±5.4 47.3±6.1 0.4800
Hbillowing (mm) 0.98±0.19 5.39±2.49
*§ 7.76±2.41* <0.0001
Vbillowing (mL) 0.05±0.02 0.69±0.46
*§ 3.25±2.64* 0.0003
Data expressed as mean ± SD. One-way ANOVA (Bonferroni post hoc): *, P<0.05 versus Normal; §, P<0.05 versus BD. FED, fibroelastic 
deficiency; BD, Barlow disease.
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Figure 3 Dynamic MV annular measurements as computed during the cardiac cycle from elaboration of CMR imaging: 2D (A) and 3D (B) 
area, perimeter (C), maximum annular height (D), intercommissural (E) and anteroposterior (F) diameters, eccentricity (G) and longitudinal 
annular displacement (H). Data expressed as mean ± SD; error bars, SEM. Bolded P value for the interaction time × group for the six phases. 
In brackets, P-value of the comparison between groups encompassing all the cardiac time points. §, statistical difference between FED and BD 
at a given time point; £, statistical difference between BD and Normal at a given time point; #, statistical difference between FED and normal 
at a given time point; *, statistical differences between the time points values in each group. SEM, tandard error of the mean; CMR, cardiac 
magnetic resonance; SD, standard deviation; FED, fibro-elastic deficiency; BD, Barlow’s disease.
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the differentiation between Normal and MV prolapse 
phenotypes through HBillowing, and between FED and BD 
through VBillowing. 
Discussion
In the present work we proposed a CMR-dedicated 
framework for the quantitative and clinical-friendly 
assessment of the dynamic changes in MV function over 
the cardiac cycle. For this purpose, the platform integrates 
radiological and bioengineering methods to provide 
an effective tool for the segmentation of CMR images, 
reconstruction of the MV apparatus and the quantification 
of relevant MV characteristics.
The results of this study clearly show that a CMR-driven 
MV analysis is feasible adopting a radial CMR sequence 
able to combine multiple long-axis planes. In particular, 
the proposed CMR analysis proved able to capture the 
physiological MV function as well as to pinpoint relevant 
differences in MV anatomy and dynamics when comparing 
FED and BD mitral prolapse phenotypes. 
Although the gold-standard 3D RT-TEE capability 
to accurately assess MV apparatus and assist MV repair 
is beyond question (9,24,25), we herein underline 
the potential of CMR as a useful preoperative tool to 
investigate MV degenerative prolapse and guide surgeons 
in the identification of the concomitant mechanisms of MV 
dysfunction. For instance, applying TEE criteria to cine 
CMR images (11), we can identify MV prolapse within each 
prolapsing scallop and effectively use the criterion of 2 mm 
of MV leaflet excursion into the left atrium (i.e., Hbillowing >2 
mm) to discriminate between normal and prolapsed MVs 
(Figure 5C).
Although several and reliable techniques for MV repair have 
spread out from the seminal Carpentier’s classification of MV 
dysfunction (3,4), no specific or quantitative recommendations 
are currently available for a systematic differentiation between 
FED and BD phenotypes (15). In this scenario, our results 
clearly support the hypothesis according to which FED and 
BD phenotypes are anatomically and functionally distinct 
(6,7,24) and these quantifiable differences may be exploited 
to help surgeons in gaining further insight into MV 
degenerative pathophysiology.
Overall MV annular dimensions (Table 2), consistently 
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Figure 5 Results of quantitative CMR-dedicated MV analysis: box and whiskers plots of billowing height (A) and billowing volume (B) as 
computed at MS in Normal, FED and BD subjects, respectively; (C) grouped scatterplot of billowing height (horizontal axis) and billowing 
volume (vertical axis) with the MV leaflets surface reported at MS for a MV from each group. *, P<0.05 versus Normal; §, P<0.05 versus BD. 
FED, fibroelastic deficiency; BD, Barlow disease; CMR, cardiac magnetic resonance; MV, mitral valve; MS, mid systole.
with previous findings (7,8,24), are markedly larger in 
BD than in Normal and FED while annular dimensions 
remain comparable between Normal and FED. Similarly, 
the significant degenerative changes in the annular shape 
(more circular in BD) and the annular height, which can 
elucidate the impact of MV degeneration on the 3D annular 
dynamics (26). Our quantification of systolic MV billowing 
well agrees with previous findings (8) showing the potential 
of both billowing height (Hbillowing, P<0.0001) and volume 
(Vbillowing, P<0.0001) to differentiate FED from BD patients 
(Figure 5C)
Over the cardiac cycle (Table 3), despite annular 
enlargement, FED and Normal annular kinematics are 
comparable but significantly differ from BD in particular 
during systole. Indeed, FED systolic annular behavior well 
resembles normal patterns of diametrical DCC and DPM 
expansion and progressive annular height increase between 
LD and MS (27). On the contrary, although maintaining a 
longitudinal and apically-oriented excursion comparable to FED 
and Normal (∆L, P Group × Phase =0.53), the BD annulus 
exhibits an early-to-late systolic abnormal enlargement (7), 
also beyond the annular diastolic dimensions, which may 
further contribute to leaflet separation and regurgitation 
during systole (6). Conversely, complementing the analysis 
with the quantification of the changes in PAPs dynamics over 
the cardiac cycle (Table 4), we notice that the PAPs dynamics 
can remain close to physiological conditions.
Hence, our analysis highlights annular alterations as 
the primary hallmark to identify severe MV degenerative 
prolapse, frequently associated with mitral annular 
disjunction (28); the unaltered behavior of MV sub-
apparatus support the hypothesis of ventricular-annular 
decoupling (6). 
In conclusion, our CMR-dedicated framework can 
be effective to gain insight into the characterization of 
degenerative phenotypes of MV prolapse, providing a 
quantitative assessment of the severity of MV dysfunction 
and potentially support the selection of the appropriate 
MV repair, according to the patient-specific clinical 
scenario. For instance, abnormal MV annular dynamics 
(e.g., excessive BD late-systolic annular enlargement) can 
be identified and referred to surgery to receive both repair 
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for MV prolapse and adequate annuloplasty to remodel MV 
annulus (29); in prolapsing FED reporting a physiological-
like dynamics, annuloplasty could be complementary during 
surgery as well as minimally-invasive MV repair, e.g., 
through a Mitraclip® (Abbott Vascular Inc., Menlo Park, 
California, US) or a Neochord® (NeoChord, Inc., Eden 
Prairie, Minnesota, US) system, could success without long-
term relapse (30).
Furthermore, from a bioengineering standpoint, the 
proposed framework can be successfully coupled with the 
computational modelling of the patient-specific clinical 
scenario (31), taking the preoperative patient-specific 
MV dynamics into account, to virtually investigate both 
advantages and drawbacks of MV surgery (20) as well as the 
outcomes of a percutaneous intervention (21).
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Supplementary appendix
Three dimensional CMR-dedicated procedure of 
MV reconstruction
Three dimensional (3D) coordinates Pi,3D, of the single 
point Pi selected during segmentation of rotational CMR 
images, are computed as:
[1]
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where the vector Pp (Pp,x; Pp,y; Pp,z) is the patient reference 
position of the plane in the global machine CMR system 
xyz, stored in the “ImagePositionPatient” DICOM field. 
Information stored in the “ImageOrientationPatient” 
DICOM field are included in V, containing the unit vectors 
vx (vx,x, vx,y, vx,z) and vy (vy,x, vy,y, vy,z) of each DICOM plane 
of sequence; subsequently, vz (vz,x, vz,y, vz,z) is obtained 
from the cross product vx × vy (Figure A1). On each cMRI 
image, point coordinates for Pi (Pi,x, Pi,y, Pi,z) are computed 
using the specific pixel dimension of the image (i.e., 1.25× 
1.25 mm), stored in the “Pixel spacing” DICOM field.
Subsequently, the geometry of MV annulus is automatically 
reconstructed through a two-step validated procedure (1,2): 
(I) a cylindrical reference frame is set with the origin in the 
center of mass of the MV annular extracted cloud of points, 
and the z-axis normal to the least-square plane of the 
annular points; (II) in this local reference frame, the radial (ρ) 
and axial (h) positions of the points belonging to the annular 
profile (Figure S1B, red line) are approximated through a 
4th order Fourier function of the angular position (ϑ) in the 
form:
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[2]
where a0, ak, bk, c0, ck and dk are the coefficients of the 
resulting Fourier function. Finally, annular characteristic 
landmarks are identified according to CMR morphological 
criteria (3). 3D coordinates of both anterolateral (PAPAL) 
and posteromedial (PAPPM) papillary muscles tips are 
identified applying a K-means partitioning algorithm to 
separate the selected papillary points during segmentation 
in two mutually exclusive clusters, thus identifying the 
centroid of each papillary muscle tip (2).
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Figure A1 3D reconstruction automatic reconstruction from CMR images. (A) schematic representation of a CMR plane with 
a point Pi selected on it; (B) result of the reconstruction of mitral annulus and the 3D position of papillary muscles tips.
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